Pregnancy-associated plasma protein A: a clinically significant predictor of early recurrence in stage II breast carcinoma.

Abstract

The primary tumors and metastases from 30 patients with stage II breast carcinoma treated with low- or standard-dose combination chemotherapy (cyclophosphamide, methotrexate, 5-fluorouracil) were studied by the immunoperoxidase technique for pregnancy-associated plasma protein A (PAPP-A), pregnancy-specific beta-1-glycoprotein (SP-1), and placental protein… (More)

Topics

  • Presentations referencing similar topics